Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/12/2024 | 30/09/2024 |
|---|---|---|---|---|---|
| Revenue | 4M | 6M | 4M | 4M | 4M |
| Cost of revenue | 3M | 3M | 3M | 2M | 2M |
| Gross profit | 2M | 2M | 1M | 1M | 1M |
| Research and development | 557,000 | 575,000 | 594,000 | 427,000 | 506,000 |
| Selling, general and administrative | 2M | 2M | 2M | 2M | 2M |
| Operating expenses | 2M | 2M | 3M | 2M | 2M |
| Operating income | −678,000 | −337,000 | −1M | −1M | −850,000 |
| Pre-tax income | −949,000 | −731,000 | −1M | −919,000 | −463,000 |
| Income tax | −130,000 | −197,000 | −1,000 | 9,000 | 147,000 |
| Net income | −819,000 | −534,000 | −1M | −928,000 | −610,000 |
| Earnings per share | −0.48 | −0.32 | −0.76 | −0.63 | −0.59 |
| Earnings per share, diluted | −0.48 | −0.32 | −0.76 | −0.63 | −0.59 |
| Weighted average shares | 2M | 2M | 2M | 1M | 1M |
| Weighted average shares, diluted | 2M | 2M | 2M | 1M | 1M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 31/08/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2M | 3M | 3M | 4M | 5M | 5M | 4M | — |
| Receivables | 3M | 2M | 3M |
| Metric | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/12/2024 | 30/09/2024 |
|---|---|---|---|---|---|
| Operating cash flow | — | — | −2M | — | — |
| Depreciation and amortisation | — | — | 36,000 | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 3M |
| 2M |
| 2M |
| 3M |
| — |
| Inventory | 4M | 4M | 4M | 4M | 3M | 3M | 3M | — |
| Current assets | 12M | 12M | 13M | 13M | 13M | 12M | 12M | — |
| Property, plant and equipment | 310,000 | 314,000 | 284,000 | 301,000 | 225,000 | 215,000 | 255,000 | — |
| Total assets | 14M | 14M | 14M | 15M | 14M | 14M | 14M | — |
| Current liabilities | 5M | 4M | 4M | 5M | 4M | 4M | 3M | — |
| Short-term debt | 222,000 | 0 | 56,000 | 139,000 | 220,000 | 0 | 82,000 | — |
| Total liabilities | 11M | 10M | 10M | 11M | 9M | 9M | 8M | — |
| Equity | 3M | 3M | 4M | 4M | 4M | 5M | 5M | — |
| Shares outstanding | 2M | 2M | 2M | 2M | 2M | 2M | 1M | 1M |
| Shares issued | 2M | 2M | 2M | 2M | 2M | 2M | 1M | — |
| Share-based compensation | 24,000 | 39,000 | 57,000 | 13,000 | 14,000 |
| Capital expenditure | — | — | 106,000 | — | — |
| Investing cash flow | — | — | −106,000 | — | — |
| Financing cash flow | — | — | −58,000 | — | — |